✦ LIBER ✦

Capecitabine/Vinorelbine: An Effective and Well-Tolerated Regimen for Women with Pretreated Advanced-Stage Breast Cancer

✍ Scribed by Franco Nolè; Chiara Catania; Elisabetta Munzone; Andrea Rocca; Elena Verri; Giuseppina Sanna; Gilda Ascione; Laura Adamoli; M.G. Zampino; Ida Minchella; Aron Goldhirsch

Book ID: 115075701
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 491 KB
Volume: 6
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2006.n.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

459 Weekly paclitaxel: an effective and

459 Weekly paclitaxel: an effective and well tolerated treatment for advanced breast cancer

✍ P. Kellokumpu-Lehtinen; R. Asola; L. Elomaa; M. Heikkinen; R. Kokko; A. Maiche; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Reduced dose capecitabine is an effectiv

Reduced dose capecitabine is an effective and well-tolerated treatment in patients with metastatic breast cancer

✍ L. El-Helw; R.E. Coleman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 178 KB

RhuMab VEGF (bevacizumab) with concurren

RhuMab VEGF (bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer: An active, well tolerated regimen

✍ C.H. Crane; L.M. Ellis; M. OReilly; L. Ho; J.L. Abbruzzese; D.B. Evans; C. Ng; C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 19 KB

Fulvestrant is an effective and well-tol

Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials

✍ Vergote, I; Robertson, J F R 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

397 Preoperative trastuzumab and vinorel

397 Preoperative trastuzumab and vinorelbine (HN) is a well-tolerated, active regimen for Her2 3+/FISH+stage II/III breast cancer

✍ L.N. Harris; H. Burstein; R. Gelman; P. Freidman; I. Kuter; V. Borges; C. Kaelin 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 155 KB

449 Capecitabine monotherapy is active,

449 Capecitabine monotherapy is active, well tolerated and provides convenient outpatient therapy for patients with taxane-pretreated advanced breast cancer: findings from an expanded access program

✍ M. Venturini; R. Bell; R. Paridaens; D. Rossner; M. Vaslamatzis; J.W.R. Nortier; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB